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Composite nanomaterials represent a new trend in the biomedical ﬁeld. Coupling inorganic/organic constituents with non-toxicity/
biocompatibility properties leads to develop the new systems having special characteristics that can be used in various bio-applications. This
paper describes the preparation and characterization of psyllium-based composites containing TiO2 nanoparticles in order to develop new
therapeutic strategies for aspirin drug delivery. The structural characteristics of obtained materials were investigated by FTIR spectroscopy. The
UV–vis spectrophotometric analysis was performed to evaluate the aspirin release behavior under different pH conditions at 37 1C. Combining
psyllium (as an excellent source of ﬁber) with TiO2 inorganic unit (as vehicle of aspirin) it was found that polymeric-TiO2 networks have
promising potential for controlled aspirin release as therapeutic agent.
& 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.
Keywords: Psyllium; Titanium dioxide; Aspirin; In vitro release1. Introduction
The class of organic/inorganic nanocomposites has already
gained an important place in materials chemistry areas with
various applications as optoelectronic devices, catalysts, sen-
sors or biomaterials [1,2]. As organic part of composite
nanomaterials various natural polymers are generally used that
can act as binders, matrix, stabilizers, emulsiﬁers, gelling
agents, etc. due to their non-toxicity, biocompatibility and
also, by availability and economical reasons [3,4]. They can be
classiﬁed depending on their source (algal, plant, microbial or
animal origin), charge (non-ionic, anionic polymers), shape
(linear or branched) or monomeric units (homo- or hetero-) [5].
As inorganic part of composite nanomaterials due to their10.1016/j.pnsc.2014.05.007
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metal (gold, silver, copper) [6] or metal oxides such as TiO2
[7] and ZnO [8] are widely used. With particle size reduction
(less than 100 nm), the physical, chemical and biological
properties can be designed for optimal size/surface character-
istics [9] to drug delivery, biodetection of pathogens or
biological molecules (proteins), tissue engineering, tumor
killing and other biomedical applications [10,11].
The embedding of nanoparticles into a polymeric matrix
leads to obtain the composite materials with multiple unique
characteristics that are derived by combining properties of
constituents into a single material. The functionalities of
components can induce physical or chemical interactions
between organic molecules and surface nanoparticles that lead
to develop more effective systems for speciﬁc applications
[1,2]. For all these aspects, the nanocomposites can provide the
opportunities to create more effective drug-delivery platforms
with high functionality, biocompatibility and minimizing
potential adverse health risks [1,2].
The efﬁcacy of non-steroidal anti-inﬂammatory drugs (NSAIDs)
(aspirin, ibuprofen, ketoprofen, diclofenac, aceclofenac etc.)Elsevier B.V. All rights reserved.
Fig. 1. FTIR spectrum of aspirin and polymeric composite materials.
Table 1
Main IR absorption bands assignments of each components of matrix.
Sample Frequencies
(cm1)
Bond vibration
Psyllium 3441 –OH stretching of the hydroxyl groups in
carbohydrates (arabinose, xylose and traces of other
sugars) [16,18]
2923 asymmetric –CH and –CH2 stretching [15,18]
1377 –CH, –CH2 and –OH in-plane bending in
carbohydrates [15,18]
1037 C–O stretching region due to C–O and C–O–C
stretching characteristic of the natural
polysaccharides [15,16,18]
893, 553 pyranose rings [15,18]
PVA 3380 O–H stretching vibration of hydroxyl groups [17]
1734 CQO stretching of the acetate group [17]
2940 backbone aliphatic –CH2 symmetric stretching [17]
2853 C–H stretching [17]
1094 C–O stretching [17]
Tween
80
3420 O–H stretching [19]
1734 CQO stretching [19]
1642 CQC stretching [19]
1351 –CH3 symmetrical [19]
1107 C–O stretching [19]
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ever, gastrointestinal, cardiovascular or renovascular adverse
events could appear during prescribing these medications [12].
In order to obtain the beneﬁt of NSAIDs as anti-inﬂammatory
and analgesic drugs and also, to reduce or remove the
mentioned effects, new strategy for drug formulations was
evaluated [12,13]. In this experimental research the applicative
potential of titanium dioxide nanoparticles associated with
psyllium-based matrix for aspirin embedding to drug delivery
is investigated.
2. Experimental details
Psyllium husk was procured from local natural products
market. Polyvinyl alcohol (Serva, Germany), Tween 80
(Merck, Germany), titanium dioxide (Degussa AG, Germany),
aspirin (Sinteza Oradea, Romania) and ethanol (Riedel-de
Haen, Germany) were used in order to obtain the proposed
materials.
The psyllium-based matrix was prepared by mixing the
natural polymer with twice distilled water in order to obtain a
2% homogenous gel material; thus an appropriate amount of
polyvinyl alcohol relating to psyllium content (1:5 mass ratio)
was added. And then, 100 mg/ml polymer of aspirin mixed
with ethanol:Tween 80 (10:1 volume ratio) was embedded in
10 ml polymer composite matrix and stirred till uniformity.
Another sample was prepared under the same condition and
then 4 mg of TiO2/1 ml polymer composite was added and
homogeneously mixed. Samples containing 1 ml of each of the
two obtained pastes were frozen and then were lyophilized
under low temperature and high vacuum in order to completely
dry the samples. Finally, two porous materials were prepared
and the samples were noted MA (free TiO2) and MAT
(containing TiO2).
The characterization of prepared materials was performed
with FTIR spectrometer terms (JASCO FT/IR-6100) using a
KBr pellet technique and in vitro drug release behavior
employing a UV–vis spectrophotometer (JASCO V-550).
The aspirin release studies were conducted using the
dissolution media that simulate gastric and intestinal ﬂuids.
Based on instructions for simulated body ﬂuids described by
Marques et al. [14] the simulated gastric medium (SGF) was
prepared using a solution 34 mM of NaCl and an appropriate
volume of HCl to obtain a solution of pH¼1.2. The
composition of intestinal ﬂuid (SIF) at pH¼6.5 included
NaCl:NaOH:NaH2PO4 in water in mass ratio of 15:1:10. If
necessary, the pH of biological ﬂuids was adjusted with 1 M
NaOH and HCl. All experiments were performed in a shaking
water bath at 3770.2 1C.
3. Results and discussion
3.1. FTIR characterizations of composite nanomaterials
The FTIR spectra of samples are presented in Fig. 1. The
prepared composites do not show signiﬁcant modiﬁcations in
the recorded spectra, except changes of absorption intensity ofthe peaks, probably due to incorporation of used constituents
in the complex structure of the psyllium. The functional groups
present in the constituents are similar, so the absorption bands
of the obtained composites overlap those of the starting
materials, especially predominant component (psyllium).
The appearance of absorption bands in the presented spectra
can be correlated with the characteristic vibrational frequencies
of functional groups from each component and they are shown
in Table 1, in agreement with the literature [15–19].
In case of aspirin, the peak about 3000 cm1 is assigned to
O–H stretching vibration of carboxylic groups [20]. The char-
acteristic peaks of the aspirin FTIR spectrum at 1757 cm1,
1692 cm1 and 1601 cm1 are attributed to O–CO– stretching
frequency, –COO vibration and respectively, to skeletal in-plane
vibration of aromatic ring [20–22]. Also, the peaks at 1304 cm1
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ester/carboxylic group [20]. The FTIR spectrum of TiO2 shows
a broad band at about 3400 cm1 due to O–H stretching
vibration due to adsorbed H2O molecules on the titanium
dioxide nanoparticles surface [23]. This band is overlapped
with broad band of hydroxyl frequencies of organic com-
pounds. In the IR-spectral regions of 653–550 cm1 (Ti–O
stretching) and 495–436 cm1 (Ti–O–Ti stretching) [24], the
vibrations are also covered by pyranose rings vibration
[18,21]. The intensity and shape changes of band observed
in 1800–1500 cm1 suggest the hydrogen bonds formation
(physical intermolecular interactions) –OH… OQC, between
–OH groups of psyllium and OQC from carboxyl group of
aspirin. These results indicate that TiO2 nanoparticles and also,
aspirin molecules have been successfully incorporated into
psyllium-based matrix.
3.2. In vitro drug release studies
The prepared lyophilized materials samples were immersed
in the simulated biological ﬂuids (SGF and SIF) and were kept
in a shaking water bath at 3770.2 1C during the drug release
experiments. At predetermined time intervals, deﬁned volume
of dissolution media was extracted for UV–vis analysis and
replaced with the same volume of fresh ﬂuids to maintain a
constant volume.
The ﬁrst step of aspirin release from psyllium-based
composite materials was studied in SGF at pH=1.2 (50 ml)
for 2 h. Then, the samples were placed in SIF at pH=6.5
(50 ml) up to 4 h for a total period of 6 h. The content ofFig. 2. Aspirin dissolution at pH 1.2 and 6.5 from polymer composite without
TiO2 content (MA sample: SD70.32) and from polymer composite with TiO2
nanoparticles (MAT sample: SD70.41).
Table 2
Kinetic models for aspirin release from psyllium-based matrices expressed by the
pH Sample Zero-order First-order
1.2 MA 0.946 0.974
MAT 0.946 0.971
6.5 MA 0.974 0.929
MAT 0.984 0.985aspirin released was measured recording the UV–vis absor-
bance of the solution at wavelength 280 nm at 10, 30, 60 and
120 min for SGF immersion and then at 1 h up to 6 h for SIF
placement. The in vitro release proﬁle of the aspirin from the
polymer composite matrix in different dissolution media was
followed over a period of approximately 6 h and is presented
in Fig. 2. Data presented in the drug release ﬁgure have lower
standard deviation (SD) that shows the release drug regularity
nearly at constant level of the drug.
It can be observed that a drug release of about 45% occurred
at pH¼1.2. The release proﬁle of aspirin shows two almost
linear regions. The ﬁrst of these regions took place in the ﬁrst
30 min that translated by a fast dissolution of aspirin from the
polymer composite matrix followed by a slower release rate
that continued for approximately 2 h. As a result of replace-
ment of composite materials in intestinal media, the aspirin
release proﬁle presents a similar trend to that mentioned above.
At pH 6.5, aspirin release was faster, roughly linear and was
reached 100%. A small difference between two release drug
proﬁles is observed in acidic media. In the ﬁrst case (MA
sample), the slight increase of drug release rate occurs due to
higher solubility of aspirin in this solution. In the second case
(MAT material), the aspirin release delay can be explained by
physical adsorption of aspirin molecules onto the TiO2
nanoparticles. A visible lower aspirin release from MAT
composites is observed in the SIF media, the highest percen-
tage reaching about 90%. Thus, the total release of drug was
highly sensitive to the contribution of titanium dioxide
nanoparticles and TiO2 amount added to the composite system
may inﬂuence the release behavior of aspirin.3.3. Drug release kinetics
In vitro release studies were performed in triplicate and the
data were ﬁtted into different kinetic models, such as: zero-
order, ﬁrst-order, Higuchi, Hixson–Crowell and Korsmeyer–
Peppas. The highest value of regression coefﬁcient (R2)
indicates a good correlation and a better linearity; the kinetic
model leads the mechanism of drug release (Table 2).
The ideal kinetic models for drug release were estimated
using the following graphical plots: cumulative amount of drug
released vs. time (zero-order model), log cumulative percen-
tage of drug remaining vs. time (ﬁrst-order model), cumulative
percentage drug release vs. square root of time (Higuchi
model), cube root of drug percentage remaining in matrix vs.
time (Hixson–Crowell model) and log cumulative percentage
drug release vs. log time (Korsmeyer–Peppas model) [25].values of regression coefﬁcient (R2).
Higuchi Hixson–Crowell Korsmeyer–Peppas
0.998 0.966 0.979
0.996 0.964 0.977
0.991 0.990 0.990
0.994 0.993 0.990
Table 3
Interpretation of diffusion release mechanisms (26–28).
Release
exponent (n)
Drug transport
mechanism
Description of the drug release kinetics
no0.5 quasi-ﬁckian
diffusion
partial diffusion
n¼0.5 ﬁckian diffusion molecular diffusion of the drug due to a
chemical potential gradient
0.5on41 non-ﬁckian
(anomalous)
diffusion
both diffusion and relaxation (erosion)
release
n¼1 Case 2 transport relaxation release polymeric matrix
n41 Super Case 2
transport
erosion of polymeric chain
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drug release vs. square root of time shows a linear relationship
that describes a Higuchi model (Fig. 3).
This relationship describes the aspirin dissolution from
psyllium-based matrix in both simulated gastric ﬂuid and also,
in simulated intestinal medium. The drug release mechanism is
dictated by the penetration of ﬂuid into matrix that dissolves
the drug and then this one diffuses into the exterior medium
[25].
Mechanism of drug release from a polymeric system was
described by plotting an exponential equation (Korsmeyer–
Peppas): Mt/M1¼ktn, where Mt/M1 corresponds to fraction of
drug released at time t, k is the diffusion rate constant and n is
the release exponent that indicates the mechanism of drug
release. Fig. 4 shows the mechanism of drug release data ﬁtted
with the Korsmeyern–Peppas model. The analysis of drug
release mechanism was performed related to different values of
n (Table 3) [26–28].
The n values for the Korsmeyer Peppas model were 0.133
for aspirin release from polymeric matrix in SGF, 0.052 for the
same sample in SIF, both n values being smaller than 0.5.
These results indicate that the releases are in agreement with a
quasi-ﬁckian diffusion mechanism. Thus, aspirin diffuses
partially through a swollen matrix as a result of structuralFig. 3. Higuchi model for mechanism of aspirin releas
Fig. 4. Korsmeyer Peppas model release kinetics of aspirearrangements in the polymer support. The active principles
partially diffuse from matrix; the process is still in evolution.
The drug release can take place during a longer time period.
4. Conclusions
The psyllium-based composites containing titanium dioxide
nanoparticles as nanomaterial matrix for aspirin drug release
were prepared. The inﬂuence of TiO2 addition as carriers ine: (a) in SGF (pH¼1.2) and (b) in SIF (pH¼6.5).
rin: (a) in SGF (pH¼1.2) and (b) in SIF (pH¼6.5).
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evaluated. A slowest delay in the release proﬁle of aspirin
from the obtained composites is observed. The results indicate
that oxide is susceptible to protect the drug, as possible
efﬁcient transporter of it. The kinetics of aspirin release was
best expressed by the Higuchi model according to drug
dissolution from polymeric matrix. The values of diffusion
parameters show a drug release mechanism controlled by a
quasi-ﬁckian diffusion type, suggesting the controlled release
of aspirin. The obtained results lead to promote psyllium-based
nanocomposite materials for biomedical applications with
further more intense investigations of the diffusion mechanism
through systems with complex interfaces.
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